Nakazawa T, Yoshie Y, Iizuka K, Kobayashi S, Aibara S, Mori M, Ono S
College of Medical Care and Technology, Gunma University.
Arerugi. 1990 Apr;39(4):384-90.
To determine why midaglizole is effective in some patients with severe asthma, we investigated the inhibitory effects of midaglizole, prazosin or yohimbine on the BHT 920-, phenylephrine-, or noradrenaline-induced contractions of canine tracheal smooth muscle. After pretreatment with atropine (10(-6) M) and propranolol (10(-6) M) and precontraction with serotonin (3 x 10(-7) M), the tracheal muscle showed contractile responses to the exogenous administration of both alpha 1 and alpha 2 adrenoceptor agonists. Every alpha antagonist inhibited these agonist-induced contractions. Inhibitory activity of midaglizole (10(-4) M) for the alpha agonists was BHT-920 greater than noradrenaline greater than or equal to phenylephrine, while that of prazosin (3 x 10(-6) M) was phenylephrine greater than noradrenaline greater than BHT-920. Moreover, yohimbine completely inhibited the contractions at the lower concentration of 3 x 10(-7) M than that of other two antagonists. Our findings demonstrate that midaglizole dose-dependently inhibits airway contractions induced by alpha adrenoceptor agonists.
为了确定米格列唑对某些重症哮喘患者有效的原因,我们研究了米格列唑、哌唑嗪或育亨宾对犬气管平滑肌由BHT 920、去氧肾上腺素或去甲肾上腺素诱导的收缩的抑制作用。在用阿托品(10⁻⁶ M)和普萘洛尔(10⁻⁶ M)预处理并以5-羟色胺(3×10⁻⁷ M)预收缩后,气管肌肉对外源性给予α1和α2肾上腺素能受体激动剂均表现出收缩反应。每种α拮抗剂均抑制这些激动剂诱导的收缩。米格列唑(10⁻⁴ M)对α激动剂的抑制活性为对BHT-920的抑制作用大于对去甲肾上腺素的抑制作用,对去甲肾上腺素的抑制作用大于或等于对去氧肾上腺素的抑制作用,而哌唑嗪(3×10⁻⁶ M)的抑制活性为对去氧肾上腺素的抑制作用大于对去甲肾上腺素的抑制作用,对去甲肾上腺素的抑制作用大于对BHT-920的抑制作用。此外,育亨宾在3×10⁻⁷ M的较低浓度下就能完全抑制收缩,这一浓度低于其他两种拮抗剂。我们的研究结果表明,米格列唑可剂量依赖性地抑制α肾上腺素能受体激动剂诱导的气道收缩。